Cargando…

Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has spread worldwide through person-to-person contact, causing a public health emergency of international concern. At present, there is no specific antiviral treatment recommended for SARS-CoV-2 infection. Liu Shen capsule (LS), a traditio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Qinhai, Pan, Weiqi, Li, Runfeng, Liu, Bin, Li, Chufang, Xie, Yuqi, Wang, Zhoulang, Zhao, Jin, Jiang, Haiming, Huang, Jicheng, Shi, Yongxia, Dai, Jun, Zheng, Kui, Li, Xiaobo, Yang, Zifeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7192119/ https://www.ncbi.nlm.nih.gov/pubmed/32360580 http://dx.doi.org/10.1016/j.phrs.2020.104850

Ejemplares similares

Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway
por: Ma, Qinhai, et al.
Publicado: (2020)

Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2)
por: Runfeng, Li, et al.
Publicado: (2020)

Corrigendum to: Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) [Pharmacol. Res. 156 (2020) 104761]
por: Runfeng, Li, et al.
Publicado: (2021)

Liu Shen Capsule Alters Airway Microbiota Composition and Metabolite Profiles in Healthy Humans
por: Wang, Xuerui, et al.
Publicado: (2022)

Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action
por: Ma, Qinhai, et al.
Publicado: (2022)

Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2
por: Ma, Qinhai, et al.
Publicado: (2021)

Letter to the Editor in response to the articles ‘Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)’ and ‘Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.’
por: Huang, Xi, et al.
Publicado: (2021)

The antiviral activity of arbidol hydrochloride against herpes simplex virus type II (HSV-2) in a mouse model of vaginitis
por: Du, Qiuling, et al.
Publicado: (2019)

Liushen Capsules, a promising clinical candidate for COVID-19, alleviates SARS-CoV-2-induced pulmonary in vivo and inhibits the proliferation of the variant virus strains in vitro
por: Ma, Qinhai, et al.
Publicado: (2022)

The Efficacy of Shen Shuaining Capsule on Chronic Kidney Disease: A Systematic Review and Meta-Analysis
por: Wang, Shanshan, et al.
Publicado: (2016)

Chaiqin Qingning Capsule Inhibits Influenza Virus Infection and Inflammation In Vitro and In Vivo
por: Zhao, Jin, et al.
Publicado: (2021)

Patient-derived avian influenza A (H5N6) virus is highly pathogenic in mice but can be effectively treated by anti-influenza polyclonal antibodies
por: Pan, Weiqi, et al.
Publicado: (2018)

Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates
por: Ma, Qinhai, et al.
Publicado: (2022)

Pharmacological Evaluation of LiuWei Zhuanggu Granules in Rats
por: Zhu, Haiming, et al.
Publicado: (2012)

Epidemiological and molecular characterization of dengue viruses imported into Guangzhou during 2009–2013
por: Shi, Yongxia, et al.
Publicado: (2016)

Study on the molecular mechanism of BuShenHuoXue capsule in treatment of steroid-induced osteonecrosis of the femoral head
por: Li, Jia-Cheng, et al.
Publicado: (2020)

Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
por: Ma, Qinhai, et al.
Publicado: (2022)

Corrigendum: Investigating the effects of Liushen Capsules (LS) on the metabolome of seasonal influenza: A randomized clinical trial
por: Ma, Qinhai, et al.
Publicado: (2023)

A Network Pharmacology Approach to Explore the Mechanism of HuangZhi YiShen Capsule for Treatment of Diabetic Kidney Disease
por: Zhou, Xue-Feng, et al.
Publicado: (2021)

San-Huang-Yi-Shen Capsule Ameliorates Diabetic Nephropathy in Rats Through Modulating the Gut Microbiota and Overall Metabolism
por: Su, Xiuhai, et al.
Publicado: (2022)

Animal models for studying coronavirus infections and developing antiviral agents and vaccines
por: Lin, Qisheng, et al.
Publicado: (2022)

Status of the LIU project
por: Rumolo, Giovanni
Publicado: (2019)

LIU Planned Activities
por: Chapochnikova, E, et al.
Publicado: (2015)

Overview of the LIU studies
por: Rumolo, Giovanni
Publicado: (2013)

Reply to Liu and Xiong
por: He, Heng, et al.
Publicado: (2022)

Effect of Shen Song Yang Xin Capsule on Myocardial Electrophysiology of Acute Atrial Fibrillation in Canine Model
por: Zhang, Kai, et al.
Publicado: (2017)

Zao Ren An Shen capsule for chronic insomnia: Study protocol for a randomized, placebo-controlled trial
por: Birling, Yoann, et al.
Publicado: (2019)

Morphologic and Molecular Characterization of a Strain of Zika Virus Imported into Guangdong, China
por: Li, Shufen, et al.
Publicado: (2017)

Preclinical Study of ZSP1273, a Potent Antiviral Inhibitor of Cap Binding to the PB2 Subunit of Influenza A Polymerase
por: Chen, Xiaoxin, et al.
Publicado: (2023)

Summary of Session 5: LIU
por: Meddahi, M, et al.
Publicado: (2015)

Status of the LIU project at CERN
por: Hanke, K, et al.
Publicado: (2014)

LIU: exploring alternative ideas
por: Damerau, H, et al.
Publicado: (2014)

Summary Session 5: LIU
por: MEDDAHI, Malika
Publicado: (2014)

First person – Ying Liu
Publicado: (2018)

First person – Jing Liu
Publicado: (2020)

Response to Liu et al.
por: Goodarzi, Mark O., et al.
Publicado: (2019)

Response to Liu et al.
por: Gkolfakis, Paraskevas, et al.
Publicado: (2020)

A Conversation with Xiaogang Liu
por: Lim, XiaoZhi
Publicado: (2020)

First person – Zhaoyang Liu
Publicado: (2019)

Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections
por: Xie, Peifang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3m8iro1ncmn3h63is72artj80f